ESR1 and breast carcinoma: We observed that SIGLEC15 expression was significantly higher in normal breast epithelial cells (MCF10A) and estrogen receptor-positive breast cancer cell lines, but markedly lower in estrogen receptor-negative breast cancer cell lines.